Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pegfilgrastim”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01169636
What this trial is testing

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
M.D. Anderson Cancer Center 62
Early research (Phase 1)Study completedNCT00612989
What this trial is testing

Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM

Who this might be right for
GlioblastomaGliosarcoma
Duke University 42
Testing effectiveness (Phase 2)Ended earlyNCT01692691
What this trial is testing

Dacarbazine and Carmustine in Metastatic Melanoma

Who this might be right for
Melanoma Metastatic
Western Regional Medical Center 1
Large-scale testing (Phase 3)Study completedNCT01735175
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Who this might be right for
Neutropenic ComplicationsBreast NeoplasmsChemotherapy-induced Neutropenia+1 more
Sandoz 316
Testing effectiveness (Phase 2)Study completedNCT00117442
What this trial is testing

Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood

Who this might be right for
Breast CancerLung CancerOvarian Cancer
Amgen 61
Not applicableEnded earlyNCT00689884
What this trial is testing

Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Dartmouth-Hitchcock Medical Center 7
Early research (Phase 1)Study completedNCT02589301
What this trial is testing

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

Who this might be right for
NeutropeniaHealthy
Eurofarma Laboratorios S.A. 100
Testing effectiveness (Phase 2)Study completedNCT00807599
What this trial is testing

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 67
Early research (Phase 1)Study completedNCT02479646
What this trial is testing

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Who this might be right for
Healthy Volunteers
Mylan Inc. 218
Testing effectiveness (Phase 2)Study completedNCT00478361
What this trial is testing

Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function

Who this might be right for
Distal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+8 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00124111
What this trial is testing

Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Amgen
Testing effectiveness (Phase 2)Study completedNCT00094809
What this trial is testing

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Who this might be right for
Colon CancerColorectal CancerRectal Cancer
Amgen 252
Early research (Phase 1)Study completedNCT04015232
What this trial is testing

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00280787
What this trial is testing

Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim

Who this might be right for
Non Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 24
Early research (Phase 1)Study completedNCT02418104
What this trial is testing

Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®

Who this might be right for
Immunity, Humoral
Coherus Oncology, Inc. 303
Not applicableUnknownNCT03846414
What this trial is testing

Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia

Who this might be right for
Chemotherapy-induced NeutropeniaMyelosuppression
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 1,500
Early research (Phase 1)Study completedNCT04873765
What this trial is testing

Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers

Who this might be right for
Neutropenia
Megalabs 72
Testing effectiveness (Phase 2)Study completedNCT01527422
What this trial is testing

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL

Who this might be right for
LymphomaNon Hodgkin's Lymphoma
Fernando Cabanillas 60
Early research (Phase 1)Study completedNCT02629562
What this trial is testing

Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

Who this might be right for
Clinical Pharmacology
Cinfa Biotech 172
Testing effectiveness (Phase 2)Study completedNCT00256360
What this trial is testing

Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer

Who this might be right for
Breast Cancer
Universitaire Ziekenhuizen KU Leuven 117
Next Page